<DOC>
	<DOC>NCT02735122</DOC>
	<brief_summary>This is a Dental Pain Study which will evaluate the analgesic onset, efficacy and safety of 1000 mg acetaminophen as two Test acetaminophen 500 mg tablets, compared with commercial products of acetaminophen 1000 mg administered as two 500 mg tablets, and ibuprofen (IBU) 400 mg following third molar (wisdom tooth) extraction.</brief_summary>
	<brief_title>Study of Acetaminophen (ACM) in Post-operative Dental Pain</brief_title>
	<detailed_description>This is a single-dose, randomized, double-blind, triple-dummy, placebo- and active controlled, parallel-group study to evaluate the analgesic onset, efficacy, and safety profile of Test ACM 1000 mg compared with two commercial products over a six-hour period after third-molar extractions. Subjects will undergo dental extraction of three or four third molars.</detailed_description>
	<mesh_term>Toothache</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1. 17 years to 50 years old 2. Weight 100 lbs or greater with a body mass index (BMI) 1830 inclusive 3. Dental extraction of three or four molars 4. Experience moderate to severe pain after extraction of third molars 5. Females of childbearing age must be willing to use acceptable method of birth control 1. Currently pregnant or planning to be pregnant or nursing a baby 2. Known allergy to acetaminophen (ACM) or nonsteroidal antiinflammatory drugs (NSAIDS) 3. Inability to swallow whole large tablets or capsules 4. Have other conditions that the investigator feels may impact subject's safety and/or the integrity of the study</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>